Celastrol ameliorates lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL/lpr mice

Celastrol ameliorates lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL/lpr mice

Objective Celastrol is a bioactive constituent extracted from Tripterygium wilfordii (thunder god vine). It has been demonstrated to have a therapeutic effect on experimental disease models for chronic inflammatory and immune disorders. In the present study, we investigated whether and how celastrol...

Full description

Bibliographic Details
Main Authors:	Ping Li, Xin Liu, Xiang Liu, Hongliang Rui, Tianhong Xie, Huiqiang Liu
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-05-01
Series:	Lupus Science and Medicine
Online Access:	https://lupus.bmj.com/content/11/1/e001057.full

Similar Items

Lupus pathogenesis and autoimmunity are exacerbated by high fat diet-induced obesity in MRL/lpr mice
by: Xin Zhang, et al.
Published: (2023-01-01)

Fas-independent T-cell apoptosis by dendritic cells controls autoimmune arthritis in MRL/lpr mice.
by: Takashi Izawa, et al.
Published: (2012-01-01)

Beneficial Effect of Bupleurum Polysaccharides on Autoimmune-Prone MRL-lpr Mice
by: Yi-Wen Jiang, et al.
Published: (2012-01-01)

The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
by: Yu Shi, et al.
Published: (2019-11-01)

LSO-105 D-ALW nanoparticles ameliorate lupus nephritis in MRL/lpr mice
by: Yaqi Wang, et al.
Published: (2023-07-01)

Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice
by: Haruki Watanabe, et al.
Published: (2017-09-01)

Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.
by: Masahiro Moritoki, et al.
Published: (2013-01-01)

Defects in the peripheral taste structure and function in the MRL/lpr mouse model of autoimmune disease.
by: Agnes Kim, et al.
Published: (2012-01-01)

STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis
by: Jianfen Zhu, et al.
Published: (2024-12-01)

Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
by: Xiaoqing Yi, et al.
Published: (2023-03-01)

Immunomodulatory effects of atorvastatin on MRL/lpr mice
by: Jing Sun, et al.
Published: (2022-12-01)

Aberrant Gut Microbiome Contributes to Intestinal Oxidative Stress, Barrier Dysfunction, Inflammation and Systemic Autoimmune Responses in MRL/lpr Mice
by: Hui Wang, et al.
Published: (2021-04-01)

201 Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL/lpr mice
by: Amr H Sawalha, et al.
Published: (2022-12-01)

MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice
by: Yuan Xia, et al.
Published: (2018-06-01)

Chlorogenic Acid Relieves the Lupus Erythematosus-like Skin Lesions and Arthritis in MRL/lpr Mice
by: Ruxuan Wang, et al.
Published: (2022-10-01)

Gut microbiota mediated the effects of high relative humidity on lupus in female MRL/lpr mice
by: Chaochao Wang, et al.
Published: (2023-05-01)

Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus-prone MRL/lpr mice
by: Xavier Cabana-Puig, et al.
Published: (2022-07-01)

Role and possible mechanism of diosmetin in alleviating nephritis response in MRL/lpr lupus nephritis mice
by: XU Mengxia, et al.
Published: (2022-06-01)

Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway
by: Dan Wu, et al.
Published: (2022-07-01)

Therapeutic Potential of Anti-Interferon α Vaccination on SjS-Related Features in the MRL/lpr Autoimmune Mouse Model
by: Martin Killian, et al.
Published: (2021-11-01)

Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model
by: Jatin Sharma, et al.
Published: (2021-03-01)

Early and Short-Term Interventions in the Gut Microbiota Affects Lupus Severity, Progression, and Treatment in MRL/lpr Mice
by: Yun Zhang, et al.
Published: (2020-04-01)

Enhanced therapeutic effects of apoptotic cell‐conditioned mesenchymal stem cells in lupus‐prone MRL/lpr mice
by: Zhuoya Zhang, et al.
Published: (2024-06-01)

1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice
by: Xuewei Li, et al.
Published: (2022-07-01)

Knockdown of KLF5 ameliorates renal fibrosis in MRL/lpr mice via inhibition of MX1 transcription
by: Shanshan Tao, et al.
Published: (2023-07-01)

The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice
by: Xiaoli Wang, et al.
Published: (2007-03-01)

hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
by: Fengbiao Guo, et al.
Published: (2023-08-01)

Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
by: Young-Eun Kim, et al.
Published: (2023-09-01)

1301 Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus- prone MRL/lpr mice
by: Zhuang Wang, et al.
Published: (2022-12-01)

Reno-Protective Effect of Realgar Nanoparticles on Lupus Nephritis of MRL/Lpr Mice through STAT1
by: Weidong Xu, et al.
Published: (2019-06-01)

Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice
by: Fleur Schaper, et al.
Published: (2016-01-01)

Prevention of immune nephritis by the small molecular weight immunomodulator iguratimod in MRL/lpr mice.
by: Qingran Yan, et al.
Published: (2014-01-01)

Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus
by: Joshua Reynolds, et al.
Published: (2024-04-01)

Lipocalin-2 drives neuropsychiatric and cutaneous disease in MRL/lpr mice
by: Sayra J. Garcia, et al.
Published: (2024-09-01)

Mesenchymal stem cells enhance CCL8 expression by podocytes in lupus-prone MRL.Fas lpr mice
by: Hyung Sook Kim, et al.
Published: (2023-08-01)

LSO-003 Effects of progesterone-induced blocking factor 1 on the alleviation of lupus nephritis in MRL/lpr mice
by: Young Eun Kim, et al.
Published: (2023-07-01)

The protective capability of Hedyotis diffusa Willd on lupus nephritis by attenuating the IL-17 expression in MRL/lpr mice
by: Ying Li, et al.
Published: (2022-07-01)

Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
by: Tamara K Nowling, et al.
Published: (2020-01-01)

Angiopoietin-like 4 (ANGPTL4) Suppression Ameliorates Lupus Nephritis in MRL/lpr Mice by Inactivating NLRP3 Inflammasome and Inhibiting Inflammatory Response
by: Dan Luo, et al.
Published: (2023-09-01)

The Protective Effects of Ultraviolet A1 Irradiation on Spontaneous Lupus Erythematosus-Like Skin Lesions in MRL/lpr Mice
by: Naoya Mikita, et al.
Published: (2009-01-01)